qure_logo.svg

AI-powered

Radiology for

Proven Results

Screenshot 2024-11-14 at 6.02.01 PM.png
Activating healthcare AI in the USA is building momentum—from expanding lung cancer surveillance to prioritizing patient cases and expediting emergency stroke care. 
Reaping the clinical, operational, and financial benefits of AI requires carefully selecting a partner with proven results. 
Qure.ai has 18 FDA clearances, 60+ published evidence papers, and an AI deployment footprint in more than 90 countries. 
Meet with us at the Radiological Society of North America (RSNA) 2024 Annual Meeting for discussion, debate, and demonstrations.

Speaking at RSNA :

Hear from the Global AI Activation Ambassadors

Group 1410090749.png

Speaker Session Dec 02, 2024 Monday

Incidental lung cancer detection on chest X-rays

Time: Monday | 11.00 AM CST

Dr. David Yankelwitz

Professor of Radiology and the Director of the Lung Biopsy Service at the Icahn School of Medicine, Mount Sinai, New York

Group 1410090747.png

Speaker Session Dec 03, 2024 Tuesday

Impact of immediate AI-enabled patient triage to chest CT on the lung cancer pathway: LungIMPACT

Time: Tuesday | 11:30 AM CST

Dr. Nick Woznitza

Consultant Radiographer UCLH and Clinical Academic Canterbury Christ Church University

Group 1410090748.png

Speaker Session Dec 04, 2024 Wednesday

The power of Chest X-ray AI and early lung cancer detection: Prelim results of RADICAL study

Time: Wednesday | 11:30 AM CST

Prof. David Lowe

Professor of Health Innovation at the University of Glasgow and Emergency Consultant at NHS Greater Glasgow and Clyde

Transforming Patient Pathways
Lung Cancer Suite | Care Coordination | ER Suite
The integration of AI is redefining patient care, especially in critical areas like emergency medicine and oncology. These innovative digital health solutions enhance diagnostic accuracy and improve care coordination, ultimately leading to better patient outcomes. 
Lung Cancer Suite – Identify | Measure | Track 
  • qXR is the world’s most widely used AI for comprehensive Chest X-ray reporting, providing pre-read assistance in <1 minute with detailed lung findings. It has been proven to detect one lung cancer case for every 1,120 chest X-rays, underscoring the solution’s efficiency and effectiveness in real-world settings.  
  • qCT helps in early detection and monitoring of lung nodules. It gives precise quantification, comprehensive characterization, and 3D visualization to ensure no missed opportunities for early intervention. Studies have shown that it delivers 35% more lung cancer referrals on CT scans, validating how the AI enables actionable outcomes.  
  • qTrack is a comprehensive lung nodule management platform that enables care coordination. Results show that it facilitates follow-ups for 78% of patients with incidental pulmonary nodules (IPNs), which is essential for continuity of care and treatment planning. 
 ER Suite - Rapid Detection and Triage
  • qER is an AI-enabled head CT solution widely deployed globally to expedite the detection, triage, and quantification of traumatic brain injuries and strokes. Studies have shown it can flag critical cases in approximately 100 seconds, helping clinicians identify suspected stroke cases or neuro-critical injuries much earlier, assisting in diagnostic decision-making and streamlining the flow of patients into treatment pathways or onward discharge. 
  • qXR-NvA is an AI solution for radiology reporting. It reads and differentiates between normal and abnormal chest X-rays to help speed up radiology reporting. Depending on regional clearances, it can categorize normal chest X-rays saving up to 2 hours per radiology reporting session.  
  • qMSK is an AI solution for fracture detection, which helps localize signs of fractures in adult patients. Studies have shown it has a sensitivity of 91%.

*Please check with our U.S team to find out about our FDA-cleared portfolio

Book a Meeting!

Swing by our booth for a demonstration and discussion over coffee!